Tuesday, September 16, 2008

Amgen Presents Upbeat Data On Bone Drug

Denosumab, a twice-yearly injection, cut post-menopausal, osteoporotic womens' risk of vertabral fracture by 68% compared with placebo.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)